# BATs in Patients With Breast Cancer and Leptomeningeal Metastases

> **NCT03661424** · PHASE1 · TERMINATED · sponsor: **University of Virginia** · enrollment: 3 (actual)

## Conditions studied

- Breast Cancer Female
- Leptomeningeal Metastases

## Interventions

- **DRUG:** HER2 BATs

## Key facts

- **NCT ID:** NCT03661424
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-26
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** slow study accrual, partially due to pandemic
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661424, "BATs in Patients With Breast Cancer and Leptomeningeal Metastases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03661424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*